MIF contributes to Trypanosoma brucei associated immunopathogenicity development.
Stijlemans B, Leng L, Brys L, Sparkes A, Vansintjan L, Caljon G, Raes G, Van Den Abbeele J, Van Ginderachter JA, Beschin A, Bucala R, De Baetselier P.
Stijlemans B, et al. Among authors: caljon g.
PLoS Pathog. 2014 Sep 25;10(9):e1004414. doi: 10.1371/journal.ppat.1004414. eCollection 2014 Sep.
PLoS Pathog. 2014.
PMID: 25255103
Free PMC article.